Hyperbilirubinemia, Neonatal

2

Review clinical trials related to Hyperbilirubinemia, Neonatal. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Role of Serum (B/A) Ratio Compared to (TSB) for Early Prediction of Bilirubin-induced Neurological Dysfunction (BIND).

The aim of this study is to evaluate serum bilirubin/albumin (B/A) ratio compared to total serum bilirubin (TSB) for early prediction of bilirubin-induced neurological dysfunction (BIND).

Participants needed: 80
Trial details
Age: 1-28Biological sex: AllType: ObservationalSponsor: alaa aboelhassan mohamed aboelhassanUpdated: Sep 19, 2024
Eligibility criteria

Age: from 1 to 28 day. [+2]

Conjugated hyperbilirubinemia. [+5]

Status: Recruiting

Validation of a Jaundice Diagnostic and Monitoring Device for Low-Resource Settings

A team of researchers at Rice University in partnership with clinicians at Queen Elizabeth Central Hospital created BiliSpec, a low-cost battery-powered reader designed to immediately quantify serum bilirubin levels from a small drop of whole blood applied to a lateral flow strip. The simple and affordable BiliSpec system offers a faster and more cost-effective means to detect neonatal jaundice in under-resourced clinics and determine when phototherapy is needed. The goal of this study is to validate the accuracy of the BiliSpec device in measuring bilirubin levels in neonates relative to the laboratory spectrophotometric bilirubinometer and transcutaneous bilirubinometer measurements.

Participants needed: 1,000
Trial details
Age: 0-28Biological sex: AllType: ObservationalSponsor: William Marsh Rice UniversityUpdated: Jun 7, 2024Locations: 3
Eligibility criteria

The patient is currently being treated at Queen Elizabeth Central Hospital or Ka... [+3]

Parent or guardian is unable or unwilling to provide informed consent. [+1]